美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Krystexxa 125293 002 351(a) pegloticase Injection Intravenous 8MG/50ML (0.16MG/ML) Single-Dose Vial 2025/08/29 Horizon Therapeutics Ireland DAC Rx Licensed N/A N/A
Leqembi IQLIK 761375 001 351(a) lecanemab-irmb Injection Subcutaneous 360MG/1.8ML (200MG/ML) Autoinjector 2025/08/29 Eisai, Incorporated Rx Licensed N/A N/A
Bildyos 761444 001 351(k) Interchangeable denosumab-nxxp Injection Subcutaneous 60MG/ML Single-Dose Vial 2025/08/29 Shanghai Henlius Biotech, Inc. Rx Licensed denosumab Prolia
Bildyos 761444 002 351(k) Interchangeable denosumab-nxxp Injection Subcutaneous 60MG/ML Pre-Filled Syringe 2025/08/29 Shanghai Henlius Biotech, Inc. Rx Licensed denosumab Prolia
Bilprevda 761444 003 351(k) Interchangeable denosumab-nxxp Injection Subcutaneous 120MG/1.7ML (70MG/ML) Single-Dose Vial 2025/08/29 Shanghai Henlius Biotech, Inc. Rx Licensed denosumab Xgeva
Comirnaty 125742 004 351(a) COVID-19 Vaccine, mRNA For Injection Intramuscular 10UG Single-Dose Vial 2025/08/27 BioNTech Manufacturing GmbH Rx Licensed N/A N/A
PAPZIMEOS 125832 001 351(a) zopapogene imadenovec-drba For Injection Subcutaneous 5x10^11PARTICLE UNITS Single-Dose Vial 2025/08/14 Precigen, Inc. Rx Licensed N/A N/A
Skytrofa 761177 010 351(a) lonapegsomatropin-tcgd For Injection Subcutaneous 0.7MG Single-Dose Cartridge 2025/07/25 Ascendis Pharma Endocrinology Division A/S Rx Licensed N/A N/A
Skytrofa 761177 011 351(a) lonapegsomatropin-tcgd For Injection Subcutaneous 1.4MG Single-Dose Cartridge 2025/07/25 Ascendis Pharma Endocrinology Division A/S Rx Licensed N/A N/A
Skytrofa 761177 012 351(a) lonapegsomatropin-tcgd For Injection Subcutaneous 1.8MG Single-Dose Cartridge 2025/07/25 Ascendis Pharma Endocrinology Division A/S Rx Licensed N/A N/A
Skytrofa 761177 013 351(a) lonapegsomatropin-tcgd For Injection Subcutaneous 2.1MG Single-Dose Cartridge 2025/07/25 Ascendis Pharma Endocrinology Division A/S Rx Licensed N/A N/A
Skytrofa 761177 014 351(a) lonapegsomatropin-tcgd For Injection Subcutaneous 2.5MG Single-Dose Cartridge 2025/07/25 Ascendis Pharma Endocrinology Division A/S Rx Licensed N/A N/A
Shingrix 125614 003 351(a) Zoster Vaccine Recombinant, Adjuvanted Injection Intramuscular 50UG Pre-Filled Syringe 2025/07/16 GlaxoSmithKline Biologicals Rx Licensed N/A
Kirsty 761188 001 351(k) Interchangeable insulin aspart-xjhz Injection Subcutaneous 300UNITS/3ML (100UNITS/ML) Autoinjector 2025/07/15 Biocon Biologics Inc. Rx Licensed insulin aspart Novolog
Kirsty 761188 002 351(k) Interchangeable insulin aspart-xjhz Injection Intravenous, Subcutaneous 1,000UNITS/10ML (100UNITS/ML) Multi-Dose Vial 2025/07/15 Biocon Biologics Inc. Rx Licensed insulin aspart Novolog
Spikevax 125752 005 351(a) COVID-19 Vaccine, mRNA Injection Intramuscular 25UG/0.25mL Pre-Filled Syringe 2025/07/09 ModernaTX, Inc. Rx Licensed N/A N/A
Lynozyfic 761400 001 351(a) linvoseltamab-gcpt Injection Intravenous 5MG/2.5ML (2MG/ML) Single-Dose Vial 2025/07/02 Regeneron Pharmaceuticals, Inc. Rx Licensed N/A N/A
Lynozyfic 761400 002 351(a) linvoseltamab-gcpt Injection Intravenous 200MG/10ML (20MG/ML) Single-Dose Vial 2025/07/02 Regeneron Pharmaceuticals, Inc. Rx Licensed N/A N/A
Pyzchiva 761373 004 351(k) Interchangeable ustekinumab-ttwe Injection Subcutaneous 45MG/0.5ML Autoinjector 2025/06/27 Samsung Bioepis Co., Ltd. Rx Licensed ustekinumab Stelara
Pyzchiva 761373 005 351(k) Interchangeable ustekinumab-ttwe Injection Subcutaneous 90MG/ML Autoinjector 2025/06/27 Samsung Bioepis Co., Ltd. Rx Licensed ustekinumab Stelara
当前数据更新日期:2026年04月12日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2026 DrugFuture->U.S. FDA Purple Book